“Low Dose (d1-5 7) Oral Etoposide Regimen in Intensively Treated Platinum-Resistant Epithelial Ovarian Cancer: The İzmir Oncology Group (IZOG) Study ”. Annals of Medical Research, vol. 27, no. 1, May 2021, pp. 0029-33, http://annalsmedres.org/index.php/aomr/article/view/591.